Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
Big Pharma are teaming up to rapidly develop and roll out millions of coronavirus tests in the coming months as part of the next phase of the government’s 5-pillar national testing strategy to identify if people have the virus.
Pharmaceutical giants like AstraZeneca and GlaxoSmithKline (GSK) have been creating new national business collaborations, to help deliver on the government’s plan to carry out 100,000 coronavirus tests a day by the end of April.
Their work primarily focuses on tests to identify whether people currently have the virus, and will be targeted on frontline healthcare and other essential workers who have the virus before deploying the tests to the wider population.
New developments from businesses working to scale-up testing programmes include:
Health Minister Lord Bethell said:
“We are rapidly scaling up the national effort to boost testing capacity for coronavirus to protect the vulnerable, support our NHS and, ultimately, save lives.
“I am proud that we have already had an impressive response from companies of different scales and from different sectors coming forward with a commitment to work together, share expertise and resources to establish a large British diagnostics industry which can help us achieve 100,000 tests a day by the end of April.
“We will do everything we can to tackle this virus and we are pooling all the resources from our world-leading life sciences industry, top universities and clinical leaders to overcome this together.
The government has set up a testing taskforce with over 100 companies and Health Secretary Matt Hancock today set out 4 challenges to industry in a webinar to help build on progress as we scale up our testing capability:
Professor John Newton, the government’s adviser on testing, who is co-ordinating the programme, said:
“I’m delighted to be overseeing this absolutely crucial project to help us achieve 100,000 tests a day by the end of April.
“We have already launched from scratch an entire new network of testing labs across the UK and, with the support of industry, we can go even further, both in support of our existing work and in developing new tests.”
This circular is being shared under the Open Government Copyright licence.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.